GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SyntekaBio Inc (XKRX:226330) » Definitions » Loans Receivable

SyntekaBio (XKRX:226330) Loans Receivable : ₩0.0 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is SyntekaBio Loans Receivable?

SyntekaBio's Loans Receivable for the quarter that ended in Dec. 2023 was ₩0.0 Mil.


SyntekaBio Loans Receivable Historical Data

The historical data trend for SyntekaBio's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SyntekaBio Loans Receivable Chart

SyntekaBio Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial - - - - -

SyntekaBio Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

SyntekaBio Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


SyntekaBio Loans Receivable Related Terms

Thank you for viewing the detailed overview of SyntekaBio's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


SyntekaBio (XKRX:226330) Business Description

Traded in Other Exchanges
N/A
Address
187, Techno 2-ro, Yuseong-gu, Bi-dong, Yongsan-dong, Megan Techno World 2nd, Daejeon, KOR, 512
SyntekaBio Inc is a bioinformatics venture firm. It is engaged in gene-related research, technology development, and genetic analysis based on the genome big data platform and artificial intelligence deep learning drug development platform. The company manages and analyzes genome analysis and massive biodata and genome.

SyntekaBio (XKRX:226330) Headlines

No Headlines